Drug-induced gingival overgrowth or enlargement manifests as abnormal growth of the
gingiva due to an adverse drug reaction (ADR) in patients treated with anticonvulsants …

Idiopathic pulmonary fibrosis (IPF) is a devastating disease of unknown etiology with limited
treatment options. The role of the immune system in IPF has received increasing attention …

Drug-influenced gingival enlargement (DIGE) or overgrowth manifests as abnormal
enlargement of the gingiva due to an adverse effect of certain drug reactions in patients …

Objective Our aim was to estimate the prevalence of gingival overgrowth (hyperplasia) and
to determine whether active molecules affect the severity of overgrowth in a group of …

Mast cells (MCs) have been discovered over 130 years ago; their function was almost
exclusively linked to allergic affections. At the time being, it is well known that MCs possess …

Aim: In this work, we compared the histological features of the gingival lesions clinically
diagnosed as fibrotic overgrowths due to various etiologic factors as well as an …

Background Gingival enlargement due to calcium channel blockers is a common complaint
reported by patients. It can be localized or generalized and can range from mild to severe …

Drug‐induced gingival overgrowth is frequently associated with three particular drugs:
phenytoin, cyclosporin, and nifedipine. As gingival enlargement develops, it affects the …

Nifedipine-induced gingival overgrowth (NIGO) is characterized by cell proliferation and
extracellular matrix (ECM) component accumulation in gingival connective tissues, with …

Gingival overgrowth is an undesirable outcome of systemic medication and is evidenced by
the accretion of collagenous components in gingival connective tissues along with diverse …